{
  "zip": "M5C 1P1",
  "sector": "Healthcare",
  "longBusinessSummary": "RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations. It offers EpifractÃ¡n, a cannabinoid pharmaceutical drug for the treatment of various medical conditions and pathologies; and CannabiPiel, a multi-use cosmetic cream for the treatment of joint pain and inflammation, as well as a range of skin disorders, including psoriasis, acne, and allergic reactions. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.",
  "city": "Toronto",
  "phone": "416 848 7744",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.rammpharma.com",
  "maxAge": 1,
  "address1": "200, 82 Richmond Street East",
  "industry": "Drug Manufacturers—Specialty & Generic",
  "previousClose": 0.3553,
  "regularMarketOpen": 0.3553,
  "twoHundredDayAverage": null,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.3553,
  "navPrice": null,
  "averageDailyVolume10Day": null,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.3553,
  "fiftyDayAverage": null,
  "trailingAnnualDividendRate": null,
  "open": 0.3553,
  "averageVolume10days": null,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.3553,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 100,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 51511396,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": null,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.3553,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 100,
  "fiftyTwoWeekHigh": 0.3553,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.3553,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.3553,
  "exchange": "PNK",
  "shortName": "RAMM PHARMA CORP",
  "longName": "RAMM Pharma Corp.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RAMMF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_608825959",
  "uuid": "ec111cb0-1803-3452-8dfd-1c37951c414f",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -1.7726401,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 0,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1572480000,
  "heldPercentInstitutions": 0.03412,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.44487998,
  "nextFiscalYearEnd": 1635638400,
  "mostRecentQuarter": 1596153600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 55357983,
  "enterpriseValue": 35431424,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.3553,
  "logo_url": "https://logo.clearbit.com/rammpharma.com"
}